Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Discovery Laboratories, Inc. (DSCO): Are Hedge Funds Right About This Stock?

How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of capital and have to conduct due diligence while choosing their next pick. They don’t always get it right, but, on average, their stock picks historically generated strong returns after adjusting for known risk factors. With this in mind, let’s take a look at the recent hedge fund activity surrounding Discovery Laboratories, Inc. (NASDAQ:DSCO).

Discovery Laboratories, Inc. (NASDAQ:DSCO) has experienced an increase in activity from the world’s largest hedge funds recently. However, the stock market is not in agreement with the hedge fund sentiment, as the shares of Discovery Laboratories, Inc. (NASDAQ:DSCO) dropped 55.88% during the quarter. In order to understand more about the hedge fund interest, we will cover hedge funds that had positions in the company, at the end of the last quarter.

One of the best ways to understand hedge fund behavior towards any stock is to study their sentiment towards companies with similar market caps. Proceeding on that approach, we will compare Discovery Laboratories, Inc. (NASDAQ:DSCO) to other stocks, including Alphatec Holdings Inc (NASDAQ:ATEC), Dover Downs Gaming & Entertainment, Inc. (NYSE:DDE), and On Track Innovations Ltd.(USA) (NASDAQ:OTIV) to get a better sense of its popularity.

Follow Windtree Therapeutics Inc (NASDAQ:WINT)
Trade (NASDAQ:WINT) Now!

To most market participants, hedge funds are seen as unimportant, old financial vehicles of yesteryear. While there are greater than 8000 funds in operation today, we hone in on the masters of this club, about 700 funds. These hedge fund managers oversee the lion’s share of all hedge funds’ total capital, and by observing their inimitable equity investments, Insider Monkey has spotted various investment strategies that have historically outrun Mr. Market. Insider Monkey’s small-cap hedge fund strategy surpassed the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Keeping this in mind, let’s analyze the latest action surrounding Discovery Laboratories, Inc. (NASDAQ:DSCO).

Hedge fund activity in Discovery Laboratories, Inc. (NASDAQ:DSCO)

At the end of the third quarter, a total of 9 of the hedge funds tracked by Insider Monkey were bullish on this stock, an increase of 13% from the previous quarter. With hedge funds’ capital changing hands, there exists a few noteworthy hedge fund managers who were boosting their stakes substantially (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Broadfin Capital, managed by Kevin Kotler, holds the largest position in Discovery Laboratories, Inc. (NASDAQ:DSCO). Broadfin Capital has a $2.8 million position in the stock, comprising 0.2% of its 13F portfolio. The second largest stake is held by James E. Flynn of Deerfield Management, with a $2.6 million position; 0.1% of its 13F portfolio is allocated to the company. Other hedge funds and institutional investors with similar optimism include Nathan Fischel’s DAFNA Capital Management, Hal Mintz’s Sabby Capital, and Anand Parekh’s Alyeska Investment Group.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.